SARONNI, DAVIDE
SARONNI, DAVIDE
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Exploring the multifaceted antitumor activity of axitinib in lung carcinoids
2024 M. Oldani, M.C. Cantone, G. Gaudenzi, S. Carra, A. Dicitore, D. Saronni, M.O. Borghi, A. Lombardi, M. Caraglia, L. Persani, G. Vitale
Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study
2023 A. Dicitore, G. Gaudenzi, S. Carra, M.C. Cantone, M. Oldani, D. Saronni, M.O. Borghi, J. Grotteschi, L. Persani, G. Vitale
Role of epigenetic therapy in the modulation of tumor growth and migration in human castration-resistant prostate cancer cells with neuroendocrine differentiation
2022 A. Dicitore, M.G. Bacalini, D. Saronni, G. Gaudenzi, M.C. Cantone, G. Gelmini, E.S. Grassi, D. Gentilini, M.O. Borghi, A.M. Di Blasio, L. Persani, P. Garagnani, C. Franceschi, G. Vitale
TYROSINE KINASE INHIBITORS IN NEUROENDOCRINE TUMORS: FROM IN VITRO TO ZEBRAFISH MODEL
2022 D. Saronni
Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
2022 D. Saronni, G. Gaudenzi, A. Dicitore, S. Carra, M.C. Cantone, M.O. Borghi, A. Barbieri, L. Mignani, L.J. Hofland, L. Persani, G. Vitale
Modeling Lung Carcinoids with Zebrafish Tumor Xenograft
2022 S. Carra, G. Gaudenzi, A. Dicitore, M.C. Cantone, A. Plebani, D. Saronni, S. Zappavigna, M. Caraglia, A. Candeo, A. Bassi, L. Persani, G. Vitale
Efficacy of a novel second-generation somatostatin-dopamine chimera (TBR-065) in human medullary thyroid cancer: a preclinical study
2021 A. Dicitore, M.C. Cantone, G. Gaudenzi, D. Saronni, S. Carra, M.O. Borghi, M. Albertelli, D. Ferone, L.J. Hofland, L. Persani, G. Vitale
Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
2021 G. Vitale, A. Cozzolino, P. Malandrino, R. Minotta, G. Puliani, D. Saronni, A. Faggiano, A. Colao
Vandetanib versus cabozantinib in medullary thyroid carcinoma: A focus on anti‐angiogenic effects in zebrafish model
2021 S. Carra, G. Gaudenzi, A. Dicitore, D. Saronni, M.C. Cantone, A. Plebani, A. Ghilardi, M.O. Borghi, L.J. Hofland, L. Persani, G. Vitale
Effetti a lungo termine degli analoghi della somatostatina in linee cellulari di tumori ipofisari GH-secernenti.
2020 D. Saronni, A. Dicitore, G. Gaudenzi, S. Carra, M.C. Cantone, M.O. Borghi, L. Persani, G. Vitale
Targeting of fibroblast growth factor receptor pathway as a new anti-tumor strategy for medullary thyroid cancer
2019 D. Saronni, A. Dicitore, G. Gaudenzi, S. Carra, M.O. Borghi, L. Persani, G. Vitale
Precision medicine in neuroendocrine neoplasms : an update on current management and future perspectives
2019 G. Gaudenzi, A. Dicitore, S. Carra, D. Saronni, C. Pozza, E. Giannetta, L. Persani, G. Vitale
Effects of human recombinant type I IFNs (IFN-α2b and IFN-β1a) on growth and migration of primary endometrial stromal cells from women with deeply infiltrating endometriosis : a preliminary study
2018 A. Dicitore, S. Castiglioni, D. Saronni, D. Gentilini, M.O. Borghi, S. Stabile, M. Vignali, A.M. Di Blasio, L. Persani, G. Vitale